Development and Characterization of 5-Fluorouracil Cubosomal Nanosponge Tablet for Colon Targeting

Authors

  • Arun Raj. R Department of Pharmaceutical Sciences, RIMSR, Centre for Professional and Advanced Studies, Rubber board P O Kottayam 686009
  • Steffy Thomas Department of Pharmaceutical Sciences, RIMSR, Centre for Professional and Advanced Studies, Rubber board P O Kottayam 686009

DOI:

https://doi.org/10.37591/(rrjops).v10i2.471

Abstract

The objective of this study was to develop nano-scale delivery system to improve nanometric size range, percentage drug entrapment efficiency, controlled release of the incorporated drug and the protection against degradation. 5-FU loaded cubosomal dispersion was prepared by the bottom up technique and formulation was characterized. From this, 5-FU cubosomal nanosponges were prepared by the emulsion solvent diffusion method using various pH dependent polymers and evaluated, encapsulation of this formulation into a tablet by direct compression method and also perform the coating of the tablet with Eudragit solution. Evaluation of 5-FU cubosomal nanosponges predicted better particle size, zeta potential, and 86.6% of drug entrapment efficiency. In vitro release profile of the drug shows that the cubosomal nanosponge tablet is mainly targeted to the colon. The drug release mechanism from the tablets was found to be Super case II transport kind of diffusion. The formulated cubosomal nanosponges mainly results in the targeted release of the drug. Cubosomal nanosponge tablet is having improved stability, penetrability, improved patient compliance, and enhanced formulation flexibility.

 

Keywords: 5-Fluorouracil, Cubosomal nanosponge, Colon targeting, Tablets, Eudragit S-100

Cite this Article

Arun Raj. R, Steffy Thomas, Development and Characterization Of 5-Fluorouracil Cubosomal Nanosponge Tablet for Colon Targeting. Research & Reviews: A Journal of Pharmaceutical Science. 2019; 10(2): 9–18p.

Downloads

Published

2019-08-26

Issue

Vol. 10 No. 2 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.